期刊文献+

BRCA1 Mutation Detection Using Fluorescent Hybridization Probes and Melting Curves

BRCA1 Mutation Detection Using Fluorescent Hybridization Probes and Melting Curves
下载PDF
导出
摘要 The BRCA1 (Breast Cancer Anti-estrogen resistance-I), early-onset gene is expressed in cells of breast and other tissue and helps to repair damaged DNA or destroy cells in cases DNA cannot be repaired. When the BRCA1 gene is damaged, then the DNA is not repaired appropriately and this enhances the risk for cancer. Fluorescence and UV-visible thermal studies were performed for WT (wild type) and MT (mutant type targets) full systems. The target DNAs used were in the form of short oligonucleotides, genomic DNA. The probe system was used for detection of WT and SNP alleles of human BRCAI [(170-190, G---~T) and (290-310, G---~T)]. The Cy5 dye attached to a probe oligonucleotide (10-mer) undergoes a fluorescence intensity change on hybridisation of the probe to the WT compared to MT targets. Our results indicate that the system consisting of the target sequence and the one probe oligonucleotides bearing the Cy5 dye assemble correctly at the specified target. Once the full system (probe and target) is arranged under suitable conditions, a red-shift emission and change in fluorescence intensity are seen at a suitable wavelength. Thermal studies also showed significant differences in T,, between WT and MT. The results suggest that the differences in the fluorescence intensity at 665 nm and the spectrophotometric T,,,cs) for the WT and MT can be attributed to the type of binding of the probe to the target. The systems were sensitive to single nucleotide polymorphisms and this may help in high throughput applications in genetic testing and molecular diagnostics.
出处 《Journal of Life Sciences》 2013年第3期236-243,共8页 生命科学(英文版)
关键词 DNA fluorescence probe BRCAI gene melting temperature anisotropy. 基因突变检测 BRCA1 杂交探针 荧光强度 熔解曲线 寡核苷酸探针 DNA片段 单核苷酸多态性
  • 相关文献

参考文献26

  • 1M. Masso, I.I. Vaisman, Knowledge-based computationalmutagenesis for predicting the disease potential of humannon-synonymous single nucleotide polymorphisms, J.Theor. Biol. 266 (2010) 560-568.
  • 2T.V. Hansen, B. Ejlertsen, A. Albrechtsen, E. Bergsten, P.Bjerregaard, T. Hansen, et al., A common GreenlandicInuit BRCA1 RING domain founder mutation, BreastCancer Res. Treat. 115 (2009) 69-76.
  • 3Y. Zhang, J. Tian, H. Li, L. Wang, X. Sun, A novel singlefluorophore-labeled double-stranded oligonucleotideprobe for fluorescence-enhanced nucleic acid detectionbased on the inherent quenching ability ofdeoxyguanosine bases and competitivestrand-displacement reaction, J. Fluoresc. 22 (2012)43-46.
  • 4J. Koch, Primed in situ labeling as a fast and sensitivemethod for the detection of specific DNA sequences inchromosomes and nuclei, Methods 9 (1996) 122-128.
  • 5M.P. Lux, P.A. Fasching, M.W. Beckmann, Hereditarybreast and ovarian cancer: Review and futureperspectives, J. Mol. Med. (Berl) 84 (2006) 16-28.
  • 6B. Kuschel, M.P. Lux, T.O. Goecke, M.W. Beckmann,Prevention and therapy for BRCA1/2 mutation carriersand women at high risk for breast and ovarian cancer, Eur.J. Cancer Prev. 9 (2000) 139-150.
  • 7A. Frolov, A.H. Prowse, L. Vanderveer, B. Bove, H. Wu,A.K. Godwin, DNA array-based method for detection oflarge rearrangements in the BRCA1 gene, GenesChromosomes Cancer 35 (2002) 232-241.
  • 8S. Gad, V. Caux-Moncoutier, S. Pages-Berhouet, M.Gauthier-Villars, I. Coupier, P. Pujol, et al. Significantcontribution of large BRCA1 gene rearrangements in 120French breast and ovarian cancer families, Oncogene 21(2002)6841-6847.
  • 9M. Grompe, FANCD2: A branch-point in DNA damageresponse, Nat. Med. 8 (2002) 555-556.
  • 10O.N. Aprelikova, B.S. Fang, E.G. Meissner, S. Cotter, M.Campbell, A. Kuthiala, et al. BRCA1 -associated growtharrest is RB-dependent, Proc. Natl. Acad. Sci. U.S.A 96(1999) 11866-11871.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部